India’s bioeconomy has grown from about $10 billion in 2014 to more than $195 billion in 2025, says Singh

The Karnataka Bioeconomy Report 2025, released by the state's IT/BT ministry, in collaboration with the Association of Biotechnology Led En...

India must lead in biotech sovereignty powered by AI. This convergence will shape healthcare, food, and biosecurity. Nations controlling bi...

Under the BioE3 Policy, 21 bioenablers will drive advanced biomanufacturing, reduce reliance on imports, generate employment, and position ...

India has launched a network of advanced biomanufacturing hubs to boost its bioeconomy and drive innovation across sectors like health, agr...

The country’s bioeconomy has made significant progress in recent times and is poised to scale greater heights in the next few years, says J...

In 2024, India's biopharma sector marked notable achievements, with approvals of key biosimilars and the launch of advanced CAR-T therapy. ...

Laurus Bio has secured ₹120 crore in equity investment from Eight Roads Ventures and F-Prime Capital, with Laurus Labs co-investing ₹40 cro...

India's BioE3 policy is set to revolutionize biotech research with AI-powered bio-foundries. These hubs will speed up experiments and valid...

The Union Cabinet, led by Prime Minister Narendra Modi, has approved the continuation of two umbrella schemes under the Department of Biote...

India's economy has grown significantly, reaching USD 130 billion in 2024 from USD 10 billion in 2014, with predictions to hit USD 300 bill...

Union Minister Jitendra Singh highlighted that bio-manufacturing is set to revolutionize the global economy, with India poised to lead due ...

India introduced the BioE3 policy to tackle challenges related to food, energy, and climate. Approved by the Union Cabinet, the policy focu...

The Union Cabinet has approved the Biotechnology for Economy, Environment, and Employment (BioE3) policy. This initiative aims to enhance r...

"India's Bio-Economy is on way to achieve 150-billion-dollar target from the current 70 billion-dollar to contribute effectively to the Pri...

Addressing a webinar titled 'Global Perspective on India's Biotech Potential: Manufacturing Hub & Foreign Investment', Kant said India is w...

The PM highlighted the need for ‘Make in India’ initiatives in medical devices so that people benefit from the fruits of advances in diagno...